Leukaemia News
Leukaemia may be a
cancer of the blood-forming cells, which are made within the bone marrow.
Leukaemia causes large numbers of white blood
cells to be produced. this will crowd the bone marrow and should affect the assembly of normal cells. an individual with
leukaemia is more likely to select up infections and have trouble getting obviate them. About 790 Victorians develop
leukaemia per annum . There are four main sorts of leukaemia. In many cases,
leukaemia are often cured or kept in check for several years.
Chemotherapy is that the main treatment. Blood
cells and
leukaemia Blood is usually made from plasma, which may be a clear fluid. Floating during this fluid are three sorts of cells, which are: red blood
cells – that carry oxygen round the body white blood
cells – that fight disease and
infection platelets – that help to prevent bleeding when it starts. Blood
cells are made within the bone marrow, which is that the spongy part within the centre of the bone. When the body is healthy, the numbers of red cells, white
cells and platelets within the blood are kept in balance. In people with leukaemia, the bone marrow makes too many abnormal white blood cells. These abnormal
cells are unable to hold out their normal function and may crowd the bone marrow. this suggests there's not enough room within the bone marrow for creating normal white blood cells, red blood
cells and platelets. White blood
cells normally help to fight infection. during a person with leukaemia, an outsized number of those
cells are abnormal. If an individual has too many abnormal white blood cells, they're more likely to select up and have trouble getting obviate infections.
High Impact List of Articles
-
Mesenchymal stem cells in the reconstruction surgery of the supraspinatus muscle lesions
Petr Smid, Martin Komzak, Radek Hart, Libor Pasa
Research Paper: Clinical Investigation
-
Mesenchymal stem cells in the reconstruction surgery of the supraspinatus muscle lesions
Petr Smid, Martin Komzak, Radek Hart, Libor Pasa
Research Paper: Clinical Investigation
-
A randomized, double-blind, controlled study to evaluate clinical efficacy and safety of novel filmogen osmotic treatment for pharyngitis
Monika Rousse, Hendrik Schutte, Martine Guy, Gael Clairefond, Ravi Shrivastava
Research Article: Clinical Investigation
-
A randomized, double-blind, controlled study to evaluate clinical efficacy and safety of novel filmogen osmotic treatment for pharyngitis
Monika Rousse, Hendrik Schutte, Martine Guy, Gael Clairefond, Ravi Shrivastava
Research Article: Clinical Investigation
-
David Doherty, co-founder of 3G doctor
David Doherty
Interview: Clinical Investigation
-
David Doherty, co-founder of 3G doctor
David Doherty
Interview: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: interpretation
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: interpretation
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Dalbavancin: re-enforcing the arsenal against Gram-positive bacteria causing skin and skin structure infections
Konstantinos Z Vardakas & Matthew E Falagas
Review: Clinical Trail Outcomes: Clinical Investigation
-
Dalbavancin: re-enforcing the arsenal against Gram-positive bacteria causing skin and skin structure infections
Konstantinos Z Vardakas & Matthew E Falagas
Review: Clinical Trail Outcomes: Clinical Investigation
-
Essential thrombocythemia: new advances in an old disease
Clodagh Keohane , Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Essential thrombocythemia: new advances in an old disease
Clodagh Keohane , Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
Relevant Topics in Clinical